DNIF yields 8.22% · MRK yields 2.81%● Live data
📍 DNIF pulled ahead of the other in Year 1
Combined, DNIF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DNIF + MRK for your $10,000?
Dividend and Income Fund is a closed-ended equity mutual fund launched and managed by Bexil Advisers LLC. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in dividend paying stocks of companies across all capitalizations. The fund also invests through closed end funds, open end funds, business development companies, exchange traded funds, and real estate investment trusts. It employs fundamental analysis with a focus on such factors as yield, financial strength, profitability, growth potential, and risks to create its portfolio. The fund benchmarks the performance of its portfolio against the Standard & Poor's 500 Composite Index. It was formerly known as Chartwell Dividend & Income Fund Inc. Dividend and Income Fund was formed on June 9, 1998 and is domiciled in the United States.
Full DNIF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.